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This paper aimed to review the literature on depression that focused on its assessment and treatment in Malaysia. PsycINFO,
Medline, local journals were searched, and 18 published articles were included in this paper. Results indicate that research on
depression in Malaysia, particularly validation studies and psychotherapy research, was weak and fragmented, with minimal
empirical evidence available. Pharmacotherapy still dominated the treatment for depression, and, in terms of psychotherapy,
Cognitive Behavioural Therapy (CBT) was recently practiced, but only a few studies have reported on the treatment eﬃcacy of
CBT. Major limitations of studies were noted, and, consequently, the problems that are associated with the implementation and
future direction of clinical and research on depression in Malaysia were discussed. In short, the contribution of empirical research
on the assessment and treatment for depression remained inconsistent and fragmented and urgently in need of further empirical
investigation.
1.Introduction
It is projected that depression, an aﬀective disturbance, will
be among the leading causes of worldwide disability, by the
year 2020 [1]. Across the Asia-Paciﬁc region, rates of current
or 1-month major depression ranged from 1.3 to 5.5% and
rates of major depression in the previous year ranged from
1 . 7t o6 . 7 %[ 2]. Malaysia is no exception; in fact, depression
is the most commonly reported mental illness in Malaysia.
Depression is by far the most important and treatable con-
dition and is projected to aﬀect approximately 2.3 million
Malaysians at some point in their lives [3]; yet depression
remains underdetected and undertreated [4].
Theories of psychological disorders (particularly depres-
sion) are both clear and abundantly found in the literature.
These theories can be broadly classiﬁed into either biological
or psychosocial. Pharmacological theories of depression,
such as amine dysregulations, are well established [5, 6]a n d
thus provide a strong foundation for the pharmacological
treatment of depression. It is clear that the eﬃcacy of antide-
pressants, such as Selective Serotonin Reuptake Inhibitors
(SSRI) and tricyclics, are well documented [7, 8]. Similarly,
psychological theories such as Beck’s cognitive theories are
well articulated and generally accepted in the West [9–11].
It is also generally accepted in the literature that Cogni-
tive Behaviour Therapy (CBT) is an eﬀective way of treating
depression [12–15].
InMalaysia,biologicaltheories,and,thus,thepharmaco-
logical treatment of depression, are commonly used in clin-
ical practices in community settings and hospitals; in fact,
this is the main form of treatment for depression in Malaysia
[16].Unsurprisingly,thedevelopmentofpsychotropicmedi-
cation in Malaysia has tended to ignore psychological aspects
in the process of disease recognition and understanding, par-
ticularly for depression [4]. While psychotherapies for the
treatmentofdepressionareappliedclinicallyinMalaysia,itis
unfortunate that no empirical evidence to support such use
has been established. Further, it is still unknown whether
psychological instruments for the assessment of depression
and the theories for depression are valid and reliable for use
in Malaysia.2 Depression Research and Treatment
Since psychological theories and, thus, treatment are
more susceptible to cultural inﬂuences, it is therefore im-
portant to establish the validity of Western-derived psycho-
logical theories and psychological instruments for use in the
treatment of depression in diﬀerent cultures, such as Malay-
sia [17, 18]. Therefore, the aims of this paper were to review
available articles related to the issues of assessment and
treatment for depression.
2. Method
2.1. Selection of Studies. A search of the literature using elec-
tronic databases for PsycINFO and Medline (1970–present)
was conducted (see Figure 1). Due to the scarcity of papers
found in electronic databases, this paper also included man-
ual searches of all available local journals in Malaysia, such
as the Malaysian Journal of Psychiatry, the ASEAN Journal of
Psychiatry, and the Journal of Malaysian Medical and Health
Science, in order to meet the objective of this paper.
The search was reﬁned to identify studies published in
English over the last 30 years that included at least a cross-
sectional and experimental study of depression using adult
participants. Adult studies were targeted, in order to elimi-
natedevelopmentaldiﬀerencesinchildoradolescentgroups.
Meta-analysis cannot be done due to the limited number of
samples, variability of instruments used to measure depres-
sion, and insuﬃcient reports on the statistical parts that are
required for a systematic review. The publication years were
chosen to incorporate the majority of studies, since the treat-
ment for depression has been designed and researched.
Searcheswereconductedusingthekeywords,assessment,
treatment, and Malaysia; and the following words in the title:
depression, depressive disorder, and mood disorder. These
keywords and title words were selected based on those found
in the majority of papers collected earlier during the review
process. Treatment keywords were combined to yield 425
citations in PsycINFO and 325 citations in Medline. The as-
sessment terms were combined to produce 26 citations in
PsycINFOand28citationsinMedline.Studieswereexcluded
for the following reasons: biological/physiological studies
ratherthantreatment/assessmentstudies,depressionwasnot
the target of treatment, stress was misinterpreted as depres-
sion, and the article was a discussion of historical data rath-
er than empirical studies.
This review process cannot exclude papers with no in-
f o rm a t i o no ne ﬀect size, as that would lead to a limited num-
ber of papers to review. This process resulted in 12 studies
that were suitable for the review. An additional six studies
taken from local journals, which met the selection criteria,
were cited in these articles and added to the review, resulting
in a total of 18 studies.
2.2. Description of Studies Reviewed. The assessment studies,
arrangedbytheiryearofpublication,arepresentedinTable1
(a key of abbreviated terms is shown below the table).
The following study features are summarised in Table 1:( a )
study number and reference, (b) the target group, (c) the
total number of participants, (d) representative of ethnicity,
26 citations in PSYCINFO and 28 citations
in Medline
Exclude studies not related to
assessment and treatment yield to 12
studies
Combine articles with 6 articles found in
local journals yield to 18 articles to
review
Combine assessment term and title
words; combine treatment term and
title words
Insert keywords: assessment, treatment,
Malaysia and title words: depression,
depressive disorder, mood disorder
Search articles via PsycINFO, Medline
425 citations in PsycINFO and 325 in
Medline
Figure 1: Flowchart of searching articles to review.
(e) gender, (f) measures used, (g) value of Cronbach’s α,( h )
validity study conducted, and (i) whether Exploratory Factor
Analysis or Conﬁrmatory Factor Analysis is conducted. The
descriptor“targetgroup”wasincludedtoinvestigatewhether
the assessment for depression was targeting patient or non-
patient samples. The sample size is important, since larger
samples are known to give more reliable and representative
results than small sample sizes (n<30). The ethnicity and
gender are important, because Malaysia is a multiethnic so-
ciety; whereas, for gender, female is the most researched gen-
der reported in studies worldwide. In order to investigate
whether the instruments used to measure depression are
validated with study on reliability and validity, the last three
categories are importantly shown in the review.
Meanwhile, for treatment studies, Table 2 summarizes all
papers that were included in this review process. The fol-
lowing study features are summarised in Table 1: (a) study
number and reference, (b) the sample and problem for treat-
ment (depression symptoms or disorder), (c) ethnicity cat-
egories,(d)gender,(e)designofstudy,(f)interventiontypes,
(g) the duration of intervention, (h) measures used, and (i)
treatment outcome. The descriptor “problem for treatment”
was included to investigate whether treatment was targetingDepression Research and Treatment 3
Table 1: Studies on the assessment of depression in Malaysia.
Study Target group n Ethnicity (%) Gender
(n or %) Measure Cronbach’s (α) Validity EFA/CFA
(1) Quek et al.
[19] Urological 237
Malays
Chinese
(majority)
Indian
NA BDI
Internal Rel.
(0.56–0.87);
test-retest
(0.56–0.87)
Discriminant;
speciﬁcity and
sensitivity
NA
(2) Azah et al.
[20] Primary care 265 Malays (100)
Male (n = 101)
Female
(n = 164)
PHQ-9,
HDRS,
HADS
Internal Rel.
(0.67);
test-retest
(0.73)
Concurrent;
speciﬁcity and
sensitivity
NA
(3) Oei and
Mukhtar [21]
Students, general
community, primary
care, and depressed
patients
1050 Malays (100)
Male (n = 270)
Female
(n = 820)
ATQ,
BDI,
DAS
Internal Rel.
(0.90)
Concurrent
and
discriminant;
speciﬁcity and
sensitivity
EFA/CFA
(4) Mukhtar and
Oei [22]
Students, general
community, primary
care, and depressed
patients
1050 Malays (100)
Male (n = 270)
Female
(n = 820)
BDI,
ATQ,
DAS
Internal Rel.
(0.90)
Concurrent
and
discriminant;
speciﬁcity and
sensitivity
EFA/CFA
(5) Ramli et al. Patients with diabetes 153
Malays (12)
Chinese (16)
Indian (17)
Male (75)
Female (78) DASS-21 Internal Rel.
(0.74–0.79) Construct CFA
(6) Mukhtar and
Oei [23]
Students, general
community, primary
care, and depressed
patients (n = 113)
1050 Malays (100)
Male (n = 270)
Female
(n = 820)
DAS,
BDI,
ATQ
Internal Rel.
(0.82)
Concurrent
and
discriminant;
speciﬁcity and
sensitivity
EFA/CFA
(7) Ramli et al. Patients at Infertility
Centre 246
Malays (230)
Chinese (7)
Indian (6)
Others (3)
Male (123)
Female (123)
DASS-21,
HADS
Internal Rel.
(0.81–0.83);
test-retest
(0.82–0.84)
Concurrent NA
Note: Key to measure: (ATQ): Automatic Thoughts Questionnaire; (BDI): Beck Depression Inventory; (DAS): Dysfunctional Attitude Scale; (DASS-21):
Depression Anxiety Stress Scale-21; (HARS): Hamilton Anxiety Rating Scale; (HDRS): Hamilton Depression Rating Scale; Hospital Anxiety and Depression
Scale; (PHQ-9): Malay Version of Brief Patient Health Questionnaire; n = No. of subjects.
patients with major versus minor depression, secondary de-
pression, or depression symptoms. The sample size is impor-
tant,sincelargersamplesareknowntogivemorereliableand
representative results than small sample sizes (n<30). Inter-
ventiontypesareimportant,inordertoinvestigatedominant
treatments sought or reported to overcome depression,
whilst the duration and number of hours of intervention
were included to give an understanding on the eﬀectiveness
of intervention related to time and cost. Finally, the type of
outcome used to measure depression is important to investi-
gate the reliability and validity of the tools used to assess de-
pression and the treatment outcome.
3. Results
3.1. Description of Studies Included in the Review. At o t a lo f
18 studies fulﬁlled the above criteria for inclusion. Of these,
seven studies were psychometric validation of a depression
instrument and 11 studies were for treatment outcome of
depression(Table2).Atotalof2,501participantswererepre-
sented, with sample sizes ranging from 1 (Studies 8, 12, and
15) to 1,050 (Studies 3, 4, and 6). A diversity of ethnicities
were represented, where Malays were the dominant ethnicity
involved in research (Studies 2, 3, 4, 6, 11, 12, 14, 15, and 18;
only Malay subjects). The majority of studies (80%) involved
participants who met research diagnostic criteria or DSM
criteria for unipolar depressive disorders, while the remain-
der examined depression symptoms in participants drawn
from at-risk groups in the community. In terms of gender,
female subjects (n = 1279) participated the most in re-
search for depression, but several studies did not report this
category (Studies 1, 11, 13, 14, and 17).
3.2. Assessment Used to Measure Depression. In a review on
assessmentsusedtomeasuredepression,threeaspectswillbe
discussed: subjects, measures used, and the statistical meth-
od.Table1showsvalidationstudiesonmeasuresusedforde-
pression reported between 2001 and 2011. The range of sub-
jectsparticipatedinthesevalidationstudiesincludestudents,
general community, and patients (urological, primary care,
psychiatric, diabetes, and infertility). The number of partici-
pants involved in these validation studies ranges from 237 to4 Depression Research and Treatment
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1,050subjects.Meanwhile,intermsofethnicity,Malaysform
the majority that have been involved in validation studies in
Malaysia. In terms of gender, females (n = 1185) and males
(n = 569) have been investigated; however, gender was not
reported in Study 1.
In terms of measure, four studies (Studies 1, 3, 4, and
6) [19, 21–23] used the Beck Depression Inventory (BDI),
followed by DASS-21 (Studies 5 and 7) [34, 35], and PHQ-
9, HDRS and HADS (Study 2) [20]. Signiﬁcantly, in Western
studies, the BDI has been established as the most commonly
used outcome measure either in a clinical setting or in
research on depression [6]. Nevertheless, recent studies [22]
support the notion that the BDI can be used as an instru-
ment with conﬁdence to measure levels of depression symp-
tomsinMalaysians.Interestingly,tworecentstudiesincluded
cognitive measures (ATQ and DAS) for depression (Studies 3
and 6). These instruments are important because the cog-
nitive behavioural approach emphasises alleviating negative
cognitions in the treatment of depression.
Meanwhile, in terms of statistical analyses, both internal
reliabilityandvalidityanalyseswerementionedinallstudies.
Speciﬁcally, BDI studies have reported Cronbach’s alpha be-
tween 0.56 to 0.90 and test-retest realibility (0.56–0.87).
Meanwhile, for DASS-21, Cronbach’s alpha and test-retest
reliability are between 0.74–0.83 and 0.82–0.84, respectively.
In addition, for the PHQ-9, HDRS and HADS, their Cron-
bach’s alpha is 0.67 and test-retest reliability is 0.73. Mean-
while, Cronbach’s α for ATQ is 0.90 and DAS is 0.82. For va-
lidity analyses, a combination of discriminate, concurrent,
construct, and concurrent validities has been reported. Sev-
eral studies also included speciﬁcity and sensitivity analysis
to discriminate whether the tool is suitable to detect symp-
toms between medical and nonmedical populations. For an
assessment to have robust and strong psychometric proper-
ties, Exploratory Factor Analysis and Conﬁrmatory Factor
Analysis are recommended, in order for a measure to be used
asavalidtool.Now,onlyrecentStudies3,4,5,and6reported
values on EFA and CFA, which has been shown to be at an
acceptable range.
To sum up this section, the above showed that two in-
struments for assessment of symptoms of depression had
good valid and reliable psychometric information and thus
can be used with some conﬁdence for clinical research.
OtherssuchasPHQ-9,HDRS,andHADShaveminimalpsy-
chometric validation information and thus must be used
with caution.
3.3. Treatment Outcome of Depression in Malaysia. Ar e v i e w
on treatment of depression that has been reported in
Malaysia includes two general approaches (a) pharmacother-
apy and (b) psychotherapy.
Eight of the 12 studies used randomised controlled trial
(RCT) type of research design, while three studies (Studies 8,
12, and 15) used case studies design. In terms of duration of
treatment, all studies from 1976 to 2007 completed the inter-
vention between 6 weeks and 17 months, but recent studies
reportedsimilarsigniﬁcantoutcomecompletedtheinterven-
tion in 4 weeks for 8 sessions of Group CBT approach. The
majority of treatment studies (see Table 2) in Malaysia were
u s i n gH D R Sa so u t c o m em e a s u r e ,b u tr e c e n ts t u d y( 1 7 )w a s
using BDI instead. The only study that used cognition mea-
sures was Study 18 that emphasises on cognitive behavioural
approach of assessment and intervention.
I nt e r m so fs u b j e c t st h a th a v eu n d e r g o n et r e a t m e n tr e -
search of depression in Malaysia, both Malays and female are
the dominant ethnic and gender that have been mostly re-
searched.OnlyStudies9,10,and16werecombiningallthree
ethnic groups in Malaysia, otherwise other studies reported
subjects and were only among Malays.
(a) Pharmacotherapy. Table 2 lists studies reported on the
usage of pharmacotherapy intervention such as Amitripty-
line (Studies 8, 9, and 14), Nomifensine (Study 8), Moclobe-
mide (Study 10), Dothepin (12, 14, and 15), Maprotiline
(12 and 14), Benzodiazepines (13), Imipramine (Study 14),
Sertraline (16 and 17) Escitalaporam (17), and Fluoxetine
(17).
Among all studies on pharmacotherapy, four studies
(Studies 9, 10, 14, and 16) [25, 26, 30, 32] were using RCT
method of research design. All four studies were using pa-
tients with depression, except Study 10 which included other
diagnosis as well besides depression such as anxiety, bipolar,
and schizophrenia. In terms of duration of treatment, most
oftheRCTstudiesforpharmacotherapycompletedthestudy
around the same time that range between six weeks and 9
weeks, and all four studies were using Hamilton Depression
Rating Scale as an outcome measure before the Beck De-
pression Inventory and Depression Anxiety Stress Scale were
validated in the country.
Besides RCT studies, interesting ﬁndings were from two
case studies using two (Study 12) and one (Study 15) Malay
patients with major depression who attributed their present-
ing symptoms to witchcraft or possession by evil spirits [28,
31]. These three patients were given dothiepin and mapro-
tiline, respectively. Razali concluded from this report that,
although patients were depressed before they went to see the
bomoh(traditionalhealer),thespeciﬁcpsychosomaticsymp-
toms developed after the bomoh convinced the patients that
they had been charmed or their superstitious beliefs had
been reinforced. They both improved slowly and were able
to resume work 3 months and 6 weeks later.
Although Razali and Hasanah [16] stated that phar-
macotherapy treatment for depression can be costeﬀective,
there still remains an absence of any systematic treatment
evaluation yet to conclude if the treatment is costeﬀective to
all patients from both rural and urban regions.
(b) Psychotherapies. Besides pharmacological treatment, pa-
tients also have the alternative choice of psychotherapy
treatments to treat symptoms of depression; several studies
[13–16] support that a combination of pharmacotherapy
and psychotherapy yields a better outcome.
In this paper, four types of psychotherapies have been re-
ported such as psychodynamic (Study 8) [24], religious psy-
chotherapy (Studies 11 and 13) [27, 29], supportive psycho-
therapy (Studies 11 and 13), individual cognitive behaviour6 Depression Research and Treatment
therapy (Study 17) [36],andgroupcognitivebehaviourther-
a p y( S t u d y1 8 )[ 33]. An item of signiﬁcance in the studies by
Azhar and Varma [27] and Razali et al. [29], Studies 11
and 13, which should be noted, is that the religious psy-
chotherapyapproachisbasedoncognitivebehaviouralinter-
vention.
RCT study has been applied in four studies (Studies 11,
13, 17, and 18) for Malay patients with depression, except
Study 18 which included patient with anxiety in their inte-
vention. There are two RCT studies using religious psycho-
therapy, one is comparing to supportive psychotherapy and
the other study was comparing to supportive psychotherapy
and benzodiazepine. Meanwhile, for Cognitive Behaviour
Therapy, Study 17 was comparing three groups of CBT with
combination of Escitalopram, Sertraline, and Fluoxetine,
respectively. The only Group CBT plus Treatment-As-Usual
(TAU) study was conducted recently by comparing with
Treatment-As-Usual group.
From all these studies, the recent study on Group CBT
reported the shortest duration of treatment which is four
weeks with eight sessions, and the outcome response is as
successful as longer session. Otherwise, other psychotherapy
studies in this review reported duration of treatment from
12 weeks to 26 weeks. However, Study 11 did not report on
duration of sessions, but only reported that 15–20 sessions
were completed by the participants.
This section also concluded that there is only one ran-
domised control study on GCBT since its introduction in
the early 1990s. Group intervention has been introduced in
Malaysia in religious psychotherapy; thus, the GCBT study
supports the notion that this form of treatment may be ap-
plicable to Malaysia, in particular the Malays as long as
therapists are sensitive to the religious-sociocultural issues
to which the group belongs. Hence, they concluded that the
cognitive-behavioural approach complements and is com-
patible with the inﬂuence of religious values and has been
especially eﬀective in treating depressed patients [27]. The
GCBT study is the ﬁrst attempt to use a manual-based in-
tervention in Malaysia, and response rates are encouraging.
Beside cognitive behaviour therapy, the eﬃcacy of psy-
chodynamic approach (Study 8) [24] cannot be concluded
as it has been reported only in one study by using a single
subject. Azhar and Varma [27] highlighted that the appli-
cability of the psychodynamic approach for Malays is not
inconsistent in Malaysia. Hatta [37] agreed that psychiatric
services in Malaysia had their roots in the Western paradigm
ofmedicalpractice,whileZain[38]warnedthatapplicability
ofpsychotherapyinMalaysia,inparticularforMalayculture,
could not readily accept the psychoanalytic model of Freud.
Thus, Zain [38] argued that psychotherapy could be an ef-
fective treatment of depression in Malaysia, if carried out
with a proper diagnosis and recruitment selection.
In terms of outcome measure, all RCT studies reported
using Hamilton Depression Rating Scale, while Study 17
used Beck Depression Inventory and Hospital Anxiety and
Depression Scale. Meanwhile, the GCBT study (Study 18),
instead of using symptom outcome measure, reported using
cognitive measures to assess the eﬀectiveness of the treat-
ment. Most of the studies did not report on follow-up ses-
sions, clinical and statistical signiﬁcance, and eﬀect size ex-
cept Study 18.
4. Discussion
This present paper aimed to review all studies performed
in Malaysia, which were divided into two themes, namely,
assessment and treatment of depression. It becomes clear
that research on depression in Malaysia has a long way to go
before psychiatric services are able to provide an ideal level
of service for the community.
Research studies vary in methodology and design and,
thus, often present with conﬂicting ﬁndings in all areas in-
cluding assessment and treatment. Consequently, small sam-
ple sizes, inadequate information on subjects’ recruitment
and randomisation of the sample, unclear diagnosis and
treatment protocol procedure, lack of validated instruments,
limited outcome measures or variables, problems with ho-
mogeneity of samples, and problems with generalisation of
the results occur. In addition, for the treatment studies, in-
f o r m a t i o no ne ﬀect sizes and also clinical signiﬁcant change
were seldom given.
For the psychometric assessment, it was unfortunate that
only one study used exploratory and conﬁrmatory factor
analysisinordertovalidatetheinstrumentsusedinMalaysia.
Thus,weakstatisticalmethodologyusedinvalidationstudies
overstated the reliability and validity of the instruments
reviewed. While the BDI had been shown to have good psy-
chometric properties, yet only Study 4 gave a precise num-
bers that used the BDI as a symptom measure for depression.
It was noted in Tables 1 and 2 most used the HDRS and the
HADS. Unfortunately, the psychometric properties of these
measures for use in Malaysia are not solid. Furthermore,
besides symptoms or mood change, cognitions have also
been proven to be important variables for depression re-
search. Only until recently that cognitive measures (Auto-
matic Thoughts Questionnaire and Dysfunctional Attitude
Scale) are validated and applied as a treatment outcome
measures in the country. Since Malaysia is a multiculture
society with 65% Malays/Bumiputera, 26% Chinese, and
7% Indians, the studies using Malay participants only may
weaken the generalisability of the validity of the instrument
for the whole of Malaysia.
5. Conclusions
In summary, there is evidence that some progress had been
madeinimprovingtheassessmentandtreatmentforpatients
with depression. Recently, an indigenously constructed and
validated instrument for the screening of mental health
problem was developed [39]. In terms of Group CBT, it
has been growing favourable by many psychiatrist and pri-
mary care personnel because it can be delivered to a large
number of participants with a minimum of time, thus mak
ing it an ideal intervention for research into, and treatment
of, depression not just in psychiatric services but also in
oncology, cardiac, and endocrine clinical services. It is
hoped that, with further research and expansion of cognitiveDepression Research and Treatment 7
behavioural model application, patients will be able to re-
ceive evidence-based and contextually such as culturally and
religiously appropriate treatments.
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